Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Posts Increased Revenues, Earnings for Q1

This article has been updated from an earlier version that misstated the percentage of revenues from life science mass spectrometry systems.

 

NEW YORK, May 5 (GenomeWeb News) - Bruker BioSciences yesterday reported increased revenues and earnings for the first quarter of 2004.

 

Revenues for the quarter were $68.2 million, up from $63.1 million during the first quarter of 2003. Approximately 40 percenrt of these revenues resulted from life science mass spectrometry systems.

 

R&D expenses increased to $10.4 million, up from $8.8 million during the year-ago period.

 

Bruker's net earnings totaled $1 million, or $.01 per share, up from a net loss of $1.6 million, or $.02 per share, during the same quarter last year.

 

As of March 31, Bruker had $76.7 million in cash and short-term investments.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.